Back to Search
Start Over
Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease: Results from a Phase 1 Randomized Trial
- Source :
- Inflammatory Bowel Diseases. 28:e143-e143
- Publication Year :
- 2022
- Publisher :
- Oxford University Press (OUP), 2022.
- Subjects :
- Gastroenterology
Immunology and Allergy
Subjects
Details
- ISSN :
- 15364844 and 10780998
- Volume :
- 28
- Database :
- OpenAIRE
- Journal :
- Inflammatory Bowel Diseases
- Accession number :
- edsair.doi...........99923af3b4806e6d67ca773f598c9d12